The Application of the Hemoglobin Saturation Sensor and ...
Transcript of The Application of the Hemoglobin Saturation Sensor and ...
KENTA TAKEDA, NOBUKAZU TANAKA, SHINICHI NISHI, and AKIRA ASADA. The Application of the Hemoglobin Saturation Sensor and Indocyanine Green (ICG) for Blood Flow Measurement. Osaka City Medical Journal. 2006, 52, 21-27
The Application of the Hemoglobin Saturation Sensor and Indocyanine Green
(ICG) for Blood Flow Measurement
KENTA TAKEDA, NOBUKAZU TANAKA, SHINICHI NISHI,
and AKIRA ASADA
Citation Osaka City Medical Journal. Issue Date 2006-06
Type Journal Article Textversion Publisher
Right © Osaka City Medical Association. https://osakashi-igakukai.com/.
Placed on: Osaka City University Repository
The Application of the Hemoglobin Saturation Sensor and Indocyanine Green (ICG) for Blood Flow Measurement
KENTA TAKEDA, NOBUKAZU TANAKA, SHINICHI NISHI, and AKIRA ASADA
Department of Anesthesiology and Intensive Care Medicine, Osaka City University, Graduate School of Medicine
- 21 -
Osaka City Med. J. Vol. 52, 21-27, 2006
Received October 7, 2005; accepted November 22, 2005.Correspondence to: Kenta Takeda, MD.
Department of Anesthesiology and Intensive Care Medicine, Osaka City University, Graduate School ofMedicine, 1-4-3, Asahimachi, Abeno-ku, Osaka 545-8586, JapanTel: +81-6-6645-2186; Fax: +81-6-6645-2489E-mail: [email protected]
AbstractBackground
The aim in this study is to evaluate a new blood flow measurement applying a hemoglobin
saturation sensor and indocyanine green (ICG) in circuit and animal models.
Methods
1) In the basic study, the blood was mixed in a tube with ICG, and a near-infrared sensor was
placed in this tube. The standard curve of the relationship between ICG concentration and
optical density was obtained. 2) In the circuit model, the blood was circulated by the roller
pump. ICG was injected in this circuit and its concentration was calculated from the change in
optical density at 810 nm. Rate of flow was calculated based on the Fick’s principle. The validity
of this method was evaluated by Bland and Altman analysis. 3) In the animal model, a
hemoglobin saturation sensor was inserted into three anesthetized dogs via the jugular vein, and
iced ICG was injected for calculating cardiac output. Cardiac output was calculated by the same
theory of the circuit model. The validity of this method was also evaluated by Bland and Altman
analysis.
Results
1) A standard curve was drawn from 11 different points (r2=0.99). 2) The calculated flow rate
correlated well with the actual flow rate (r2=0.97). 3) The calculated cardiac output correlated
well with results obtained with the thermodilution method.
Conclusions
Application of a hemoglobin saturation sensor and ICG to blood flow measurement was
reliable and useful in both circuit and animal models. This method may be clinically useful for
measurement of blood flow.
Key Words: Hemoglobin saturation sensor; Indocyanine green; Near-infrared light;
Blood flow measurement; Thermodilution method
IntroductionIn critically ill patients, it is important to assess organ perfusion. Inadequate splanchnic
blood flow may cause organ failure (ischemic brain, ischemic heart failure, liver failure or renal
failure etc.) and increase mortality in such patients. Various methods have already been
reported for measurement of blood flow in organ, including thermodilution, lithium dilution,
electromagnetic, blood flowmetry, and Doppler ultrasound technique1-5). We have also reported
the measurement of hepatic blood flow using changes in hemoglobin saturation with a
pulmonary artery catheter inserted in the inferior vena cava in critically ill patients6) and the
measurement of coronary blood flow using lithium dilution in an animal model7). But some
problems were pointed in our previous report. One is the limitation of lithium clinical use in
Japan. Indocyanine green (ICG) as a new indicator that has no limitation in clinical use, was
picked up in this study.
ICG has been used in the dye dilution method to measure cardiac output. The change in
hemoglobin saturation injected by ICG is sometimes experienced in clinical practice. This
phenomenon may result from change in optical density at red and near-infrared wavelengths.
The hemoglobin saturation derived from pulse oximetry (SpO2) is decreased by ICG, because
SpO2 is related to the ratio of absorption optical intensities at 660 nm and 940 nm, and more
decrease is observed at 660 nm than at 940 nm when ICG is administrated8). On the other hand,
mixed venous hemoglobin saturation (SvO2) is increased by ICG, because SvO2 is related to the
ratio of reflection optical intensities at 810 nm and 750 nm, and the optical intensity at 750 nm
is more decrease than at 810 nm when ICG is administrated9). The near-infrared light 810 nm
was peculiar in the reflection absorbance of ICG10,11).
The purpose of this study was to determine whether a new method, involving determination
of the change in optical density at 810 nm induced by ICG injection, is as reliable and accurate
as the usual method. We studied the accuracy and reliability of this new method using circuit
and animal models.
MethodsBasic study
The packed blood for transfusion was mixed in a tube with ICG (0 to 12.5 mg/L). A near
infrared light reflection sensor (flow-directed thermodilution fiberoptic continuous cardiac output
pulmonary artery catheter (Opti-Q, Model 05250901, Abbott Laboratories, North Chicago,
IL60064, USA) was placed in this tube. The SvO2 monitor (OX3-60, Model 05973763, Abbott
Laboratories) connected with this sensor to display reflection optical intensity ratio at three
wavelengths of light: 660 nm, 750 nm, and 810 nm. Hemoglobin oxygen saturation was
calculated based on the Lambert-Beer’s law8). The principle for two different situations, absorbed
and reflected lights, is based on the same energy kinetics. ICG concentration was calculated
from ICG optical density at 810 nm by applying Lambert-Beer’s law using the following below
equation.
ICG optical density = -log (I/I0)
I, ICG reflection intensity; I0, blood reflection intensity
- 22 -
Takeda et al
The standard curve of the relationship ICG concentration and optical density at 810 nm was
derived for the conversion from optical density to concentration.
Circuit model
The packed blood for transfusion was circulated in a circuit containing a roller pump for the
regulation of flow (50 to 300 mL/min) (Fig. 1). The near-infrared light of 810 nm reflection
sensor was placed in this circuit, and 0.5 mg of ICG with 0.5 mL of saline was injected into the
circuit before the sensor. The same amount of ICG was injected at five times in each flow rate.
The change in ICG optical density was converted to ICG concentration using the equation given
above. The area under the time-ICG concentration curve (AUC) was calculated by the
trapezoidal rule. Flow rate was calculated based on the Fick’s principle12) from the derived AUC
(Calculated Flow Rate). The difference between Calculated Flow Rate and pump flow rate
(Actual Flow Rate) was examined by Bland and Altman analysis13).
- 23 -
The Hemoglobin Saturation Sensor for Blood Flow Measurement
Scheme of the flow model and ICG concentration curve. The blood for transfusion was circulated ina circuit by a roller pump to regulate flow rate (50 to 300 mL/min). The ICG sensor was placed in this circuit,and 0.5 mg (0.5 mL) of ICG was injected into the circuit passing the sensor.
Figure 1.
Animal model
Following approval by the Institutional Animal Care and Use Committee, three beagle dogs,
one male and two females, weighing 8-10 kg were included in this study. After induction of
anesthesia and tracheal intubation, an 8 Fr of pulmonary artery catheter (Opti-Q) was inserted
via the right or left jugular vein through a 8.5 Fr of sheath (Percutaneous Sheath Introducer Set,
Product No. SI-09875-E, Arrow International, Inc. 2400 Bernville Road Reading, PA 19605
USA). The catheter was placed in the pulmonary artery by using the flow directed method. The
position of the catheter was confirmed by the radio imaging and the pressure waveform. After
the catheter was connected with the continuous cardiac output computer (Q-Vue, Model 052230,
Abbott Laboratories), 5 mg of ICG diluted with 3 mL of iced saline was injected using the
thermodilution method. The change in reflected optical density at near-infrared light 810 nm
was recorded through the SvO2 monitor and the blood flow rate was calculated using the same
theory as for the circuit model. The difference in cardiac output values obtained the
thermodilution method and our new method was examined by Bland and Altman analysis.
ResultsBasic study
A standard curve was drawn from 11 different ICG concentrations and optical densities (Fig.
2). The standard regression line was calculated as below:
ICG concentration (mg/L) = ICG optical density×45.24+0.05 (r2=0.99, p=0.001)
Circuit model
The calculated flow rate by our new method correlated well with the actual flow rate (Fig. 3).
The coefficient of correlation between the calculated and actual flow rates was 0.989. The results
- 24 -
Takeda et al
Standard curve for ICG in staticstatus.Figure 2.
Correlation between calculatedand actual flow rates in circuit model.Figure 3.
Bland and Altman analysis of flow ratescalculated with our new method and actual flowrates as a gold standard in the circuit model.
Figure 4.
of Bland and Altman analysis between the calculated and actual flow rates are shown in Figure
4. The overall bias was 7.6 mL/min, the upper 95% limit of agreement was 13.8 mL/min and the
lower 95% limit of agreement was 29.0 mL/min.
Animal model
The change in ICG concentration was shown as a large peak in the first circulation and
subsequent small peaks (Fig. 5). The area under the concentration-time curve was calculated by
the Stewart-Hamilton method14), and converted cardiac output. The results of Bland and Altman
analysis are shown in Figure 6. The overall bias was 0.5 L/min, the upper 95% limit of
agreement was 3.1 L/min, and the lower 95% limit of agreement was 2.1 L/min.
DiscussionOne of the reasons why ICG has been used in physiological studies is that concentrations of it
can be determined spectrologically. On the other hand, the pulse oximetry method, which can be
applied to determine the change in optical density in transmitted red and near-infrared light,
has been used for bedside monitoring in worldwide. It has been suspected that the change in
optical density at another wavelength for detecting the intensity of green due to ICG in blood
might be useful for assay of ICG concentration. This principle is applied in the DDG2001
analyzer (Nihon Kohden Corp, Tokyo, Japan), which can measure the changes in optical density
using a finger or a nose probe15,16), and which can be used for bedside estimation of cardiac output
and liver blood flow. However, since the wavelength in near-infrared light was well studied and
stable optical density, we hypothesized that change in optical density in pulse oximetry area
would represent ICG concentration.
A standard curve was needed to convert optical density change in near-infrared light of 810
nm to ICG concentration. A good correlation was found between optical density and ICG
concentration, and conversion from optical density to concentration was performed after this
basic study. After this static conversion, dynamic conversion was performed using the circuit
model and cardiac output measurement. Our new method was verified by Bland and Altman
analysis, with use of the roller pump flow rate for the circuit model and the thermodilution
- 25 -
The Hemoglobin Saturation Sensor for Blood Flow Measurement
ICG concentration curve in ananimal model.Figure 5. Bland and Altman analysis of the
new method and thermodilution method in ananimal model.
Figure 6.
- 26 -
Takeda et al
method for the animal model as respective gold standards. The major differences between our
method and the gold standard were not found in both models. However, it will be necessary to
verify our new method for various cardiac outputs, because cardiac output varies considerably in
various clinical situations, such as sepsis with high cardiac output, myocardial infarction.
Two options were considered in examing whether the change in optical density at near-
infrared light revealed change in ICG concentration. One was use of transmitted light in a
finger probe, while the other was use of reflected light in a catheter sensor. A blood vessel sensor
was selected for use in this study, because the transmitted light is affected by peripheral
circulatory change17). Another problem with use of ICG as a marker dye is that ICG is
metabolized slowly in the liver, and accumulates when repeatedly injected. This problem will be
settled by the translocation of the basic line of optical density to apply the calibration.
Moreover, ICG is unstable when dissolved in water18). It is necessary to inject ICG rapidly for
measurement of blood flow rate soon after its dissolution. This may cause anaphylactic shock19).
We have already reported the measurement method of hepatic blood flow using changes in
hemoglobin saturation by the pulmonary artery catheter inserted in the inferior vena cava in
critically ill patients6) and the measurement method of coronary blood flow using lithium dilution
in an animal model7). The former method for measurement of liver blood flow is based on the fact
that the confluent flow is the sum of two previous flows. That is, the subtraction of the
measurement value in two points, before the meeting point of the hepatic vein and after it in the
vena cava, will represent liver blood flow. Our new method in this study can be applied to
measurement of liver or kidney blood flow using the same theory. And the latter method of
measurement of coronary blood flow was based on the fact that a lithium sensor on the tricuspid
valve in the right atrium can detect the lithium concentration peak by the coronary flow before
the peak by the systemic flow. Our new method in this study can also be applied to
measurement of coronary blood flow using the same theory. Critically ill patients are often
monitored mixed venous hemoglobin saturation, especially in septic status following the recent
strategy of SCCM20). Our new method in this study will not require additional catheter
insertions in patients.
In conclusion, we have shown that a new blood flow measurement method applying the
hemoglobin saturation sensor and indocyanine green is reliable and accurate in a circuit model,
and that it can be applied to measurement of cardiac output in an animal model. This method
will be clinically useful for measurement of blood flow in certain organs.
References1. Khouri EM, Gregg DE. Miniature electromagnetic flow meter applicable to coronary arteries. J Appl
Physiol 1963;18:224-227.2. Wyatt DG. Blood flow and blood velocity measurement in vivo by electromagnetic induction. Med Biog Eng
Comput 1984;22:193-211.3. Burns PN. The physical principles of Doppler and spectral analysis. J Clin Ultrasound 1987;15:567-590.4. Linton RA, Band DM, Haire KM. A new method of measuring cardiac output in man using lithium dilution.
Br J Anaesth 1993;71:262-266.5. Linton R, Band D, O'Brien T, Jonas M, Leach R. Lithium dilution cardiac output measurement: a
comparison with thermodilution. Crit Care Med 1997;25:1796-1800.6. Umemoto Y, Nishi S, Shindoh M, Asada A. Venous blood flow measurement by determination of change in
venous hemoglobin saturation. Crit Care Med 2000;28:3181-3184.7. Tanaka N, Takeda K, Nishi S, Asada A. A new method for measuring total coronary blood flow using the
lithium dilution method. Osaka City Med J 2005;51:11-18.
8. Kevin K, Steven JB. Pulse oximetry. Anesthesiology 1989;70:98-108.9. Kupeli IA, Satwicz PR. Mixed venous oximetry. Int Anesthesiol Clin 1989;27:176-183.
10. Wagner BP, Gertsch S, Ammann RA, Pfenninger J. Reproducibility of the blood flow index as noninvasive,bedside estimation of cerebral blood flow. Intensive Care Med 2003;29:196-200.
11. Landsman ML, Kwant G, Mook GA, Zijlstra WG. Light-absorbing properties, stability, and spectralstabilization of indocyanine green. J Appl Physiol 1976;40:575-583.
12. Pomes Iparraguirre H, Giniger R, Garber VA, Quiroga E, Jorge MA. Comparison between measured andfick-derived values of hemodynamic and oxymetric variables in patients with acute myocardial infarction.Am J Med 1988;85:349-352.
13. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinicalmeasurement. Lancet 1986;1:307-310.
14. Stanley TEⅢ, Reves JG. Cardiovascular monitoring. In: Miller RD editor Anesthesia. 4th ed. New York:Churchill Livingstone; 1994. pp. 1161-1228.
15. Grasberger RC, Yeston NS. Less-invasive cardiac output monitoring by earpiece densitometory. Crit CareMed 1986;14:577-579.
16. Hedenstierna G, Schildt B. Cardiac output determinations with ear piece densitometry. Ups J Med Sci 1975;80:7-10.
17. Hofer CK, Bühlman S, Klaghofer R, Genoni M, Zollinger A. Pulse dye densitometry with two differentsensor types for cardiac output measurement after cardiac surgery: a comparison with the thermodilutiontechnique. Acta Anaesthesiol Scand 2004;48:653-657.
18. Maarek JM, Holschneider DP, Harimoto J. Fluorescence of indocyanine green in blood: intensitydependence on concentration and stabilization with sodium polyaspartate. J Photochem Photobiol B 2001;65:157-164.
19. Hope-Ross M, Yannuzzi LA, Gragoudas ES, Guyer DR, Slakter JS, Sorenson JA, et al. Adverse reactionsdue to indocyanine green. Ophthalmology 1994;101:529-533.
20. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaignguidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-873.
- 27 -
The Hemoglobin Saturation Sensor for Blood Flow Measurement